NCT02033200View on ClinicalTrials.gov

Safety Study Looking at the Effects of Stendra on Vision

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Vision
Interventions
DRUG

Stendra 200 mg

DRUG

Placebo

Trial Locations (1)

85283

Celerion Inc, Tempe

All Listed Sponsors
lead

VIVUS LLC

INDUSTRY

NCT02033200 - Safety Study Looking at the Effects of Stendra on Vision | Biotech Hunter | Biotech Hunter